Developing Quality Clinical Practice Guidelines

Natalie Spearing BSN, MBA
{"title":"Developing Quality Clinical Practice Guidelines","authors":"Natalie Spearing BSN, MBA","doi":"10.1071/HI07048","DOIUrl":null,"url":null,"abstract":"<div><p>Technological advances have increased our capacity to access information and advance knowledge. In healthcare this has created the imperative to base practice on scientific evidence rather than opinion. Evidence-based guidelines can provide a link between evidence and practice by translating research findings into actionable recommendations. Therefore, the quality of guidelines is important, as they are used to inform practices that have an impact on health outcomes.</p><p>The process of developing infection control guidelines has traditionally relied on consensus among experts and literature reviews, rather than a systematic approach to locating, appraising and applying the available evidence. There is increasing expectation on the part of consumers, clinicians, governments and other stakeholders that recommended practices should be explicitly linked to the best available evidence and developed according to acceptable methodological standards. While there is room to improve the way in which infection control guidelines are developed, the skills, time and financial resources needed to undertake the development of evidence-based guidelines are substantial and often underestimated.</p><p>This article is based on the guideline development literature and on the personal experiences of the author, who has been involved in the development of consensus-based and evidence-based guidelines. It provides an overview of the purpose of clinical practice guidelines, methods of guideline development, implementation and revision strategies and areas to consider when developing infection control guidelines in the future.</p></div>","PeriodicalId":92877,"journal":{"name":"Australian infection control : official journal of the Australian Infection Control Association Inc","volume":"12 2","pages":"Pages 48, 50-54"},"PeriodicalIF":0.0000,"publicationDate":"2007-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1071/HI07048","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian infection control : official journal of the Australian Infection Control Association Inc","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1329936016300189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Technological advances have increased our capacity to access information and advance knowledge. In healthcare this has created the imperative to base practice on scientific evidence rather than opinion. Evidence-based guidelines can provide a link between evidence and practice by translating research findings into actionable recommendations. Therefore, the quality of guidelines is important, as they are used to inform practices that have an impact on health outcomes.

The process of developing infection control guidelines has traditionally relied on consensus among experts and literature reviews, rather than a systematic approach to locating, appraising and applying the available evidence. There is increasing expectation on the part of consumers, clinicians, governments and other stakeholders that recommended practices should be explicitly linked to the best available evidence and developed according to acceptable methodological standards. While there is room to improve the way in which infection control guidelines are developed, the skills, time and financial resources needed to undertake the development of evidence-based guidelines are substantial and often underestimated.

This article is based on the guideline development literature and on the personal experiences of the author, who has been involved in the development of consensus-based and evidence-based guidelines. It provides an overview of the purpose of clinical practice guidelines, methods of guideline development, implementation and revision strategies and areas to consider when developing infection control guidelines in the future.

制定高质量临床实践指南
技术进步提高了我们获取信息和推进知识的能力。在医疗保健领域,这使得必须将实践建立在科学证据而不是意见的基础上。基于证据的指南可以将研究成果转化为可操作的建议,从而在证据和实践之间建立联系。因此,指南的质量很重要,因为它们被用来为影响健康结果的做法提供信息。传统上,制定感染控制指南的过程依赖于专家之间的共识和文献综述,而不是对现有证据进行定位、评估和应用的系统方法。消费者、临床医生、政府和其他利益攸关方越来越期望建议的做法应明确与现有的最佳证据联系起来,并根据可接受的方法标准制定。虽然制定感染控制指南的方式仍有改进的余地,但制定循证指南所需的技能、时间和财政资源是巨大的,而且往往被低估。本文基于指南制定文献和作者的个人经历,作者参与了基于共识和循证指南的制定。它概述了临床实践指南的目的、指南制定的方法、实施和修订策略以及未来制定感染控制指南时需要考虑的领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信